Living a burdensome and demanding life: A qualitative systematic review of the patients experiences of peripheral arterial disease

Ukachukwu Okoroafor Abaraogu, Elochukwu Fortune Ezenwankwo, Philippa Margaret Dall, Chris Andrew Seenan, Ukachukwu Okoroafor Abaraogu, Elochukwu Fortune Ezenwankwo, Philippa Margaret Dall, Chris Andrew Seenan

Abstract

Background: Peripheral arterial disease (PAD) has a significant negative impact on the quality of life of individuals. Understanding the experiences of people living with PAD will be useful in developing comprehensive patient-centred secondary prevention therapies for this population.

Aim: The aim of this study is to identify first-hand accounts of patients' experiences of living with PAD.

Methods: Six databases (CINALH, PsyclNFO, MEDLINE, AMED, EMBASE, Social citation index/Science citation index via Web of Science (WOS)) and reference lists of identified studies were searched until September 2017 (updated February 2018). Qualitative studies reporting patients' account of living with PAD were eligible for inclusion. A framework thematic synthesis was implemented.

Results: Fourteen studies with 360 participants were included. Pain and walking limitation were recurrent among the varied symptom descriptions. Patients' ignorance and trivialisation of symptoms contributed to delays in diagnosis. Inadequate engagement in disease understanding and treatment decisions meant patients had poor attitudes towards walking treatments and unrealistic expectations about surgery. Depending on symptom progression, patients battle with walking impairment, powerlessness, and loss of independence which were a source of burden to them. Lack of disease understanding is central through patients' journey with PAD and, although they subsequently began adaptation to long term living with PAD, many worried about their future.

Conclusions: Disease understanding is vital across the illness trajectory in patients with PAD. Although certain experiences are common throughout patient journey, some might be unique to a particular stage (e.g. unrealistic expectation about surgery, or rationale of walking in spite of pain in a supervised exercise program). Given that PAD is an overarching construct ranging from the mildest form of intermittent claudication to severe critical limb ischemia with ulceration and gangrene, consideration of important patient constructs specific to each stage of the disease may enhance treatment success. Systematic review registration CRD42017070417.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. PRISMA flow diagram for patients…
Fig 1. PRISMA flow diagram for patients experiences of living with peripheral arterial disease.
Fig 2. Framework synthesis of patients experiences…
Fig 2. Framework synthesis of patients experiences of living with peripheral arterial disease.

References

    1. Maksimovic M, Vlajinac H, Marinkovic J, Kocev N, Voskresenski T, Radak D. Health-related quality of life among patients with peripheral arterial disease. Angiology 2014;65:501–6.
    1. Nordanstig J, Wann-Hansson C, Karlsson J, Lundström M, Pettersson M, Morgan MBF. Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease. J Vasc Surg 2014;59
    1. Dumville JC, Lee AJ, Smith FB, Fowkes FGR. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pract 2004;54:826–31.
    1. Hirsch AT, Haskal Z, Hertzer N, Bakal C, Creanger M, Halperin J, et al. ACC/AHA 2005 practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). Circulation 2005;113:1474–547.
    1. Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg 2015;61:2S–41S.
    1. World Health Organization. WHO—ADHERENCE TO LONG-TERM THERAPIES: EVIDENCE FOR ACTION. WHO 2015:Cap XIII 107–114.
    1. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1
    1. Cooke A, Smith D, Booth A. Beyond PICO: The SPIDER tool for qualitative evidence synthesis. Qual Health Res 2012;22:1435–43.
    1. Critical Appraisal Skills Programme (CASP). CASP Qualitative Checklist. CASP Checklists 2014. .
    1. Galea HMN, Weinman JA, Bearne LM. “You can”t walk with cramp!’ A qualitative exploration of individuals’ beliefs and experiences of walking as treatment for intermittent claudication. J Health Psychol 2017;22:255–65.
    1. Harwood AE, Broadbent E, Totty JP, Smith GE, Chetter IC. “Intermittent claudication a real pain in the calf”—Patient experience of diagnosis and treatment with a supervised exercise program. J Vasc Nurs 2017;35:131–5.
    1. Hallin A, Bergqvist D, Fugl-Meyer K, Holmberg L. Areas of concern, quality of life and life satisfaction in patients with peripheral vascular disease. Eur J Vasc Endovasc Surg 2002;24:255–63.
    1. Schorr EN, Peden-McAlpine C, Treat-Jacobson D, Lindquist R. Characterization of the peripheral artery disease symptom experience. Geriatr Nurs (Minneap) 2015;36:293–300.
    1. Johnstone CC. Living with peripheral vascular disease: patients and their carers. Nurs Times 2004;100:36–9.
    1. Gibson JM, Kenrick M. Pain and powerlessness: the experience of living with peripheral vascular disease. J Adv Nurs 1998;27:737–45.
    1. Egberg L, Andreassen S, Mattiasson AC. Experiences of living with intermittent claudication. J Vasc Nurs 2012;30:5–10.
    1. Gorely T, Crank H, Humphreys L, Nawaz S, Tew GA. “Standing still in the street”: Experiences, knowledge and beliefs of patients with intermittent claudication-A qualitative study. J Vasc Nurs 2015;33:4–9.
    1. Treat-Jacobson D, Halverson SL, Ratchford A, Regensteiner JG, Lindquist R, Hirsch AT. A patient-derived Perspective of Health-related Quality of Life With Peripheral Arterial Disease. J Nurs Scholarsh 2002;34:55–60.
    1. Wann-Hansson C, Wennick A. How do patients with peripheral arterial disease communicate their knowledge about their illness and treatments? A qualitative descriptive study. BMC Nurs 2016;15:29 10.1016/S0140-6736(13)61249-0.
    1. Wann-Hansson C, Hallberg IR, Klevsgård R, Andersson E. Patients’ experiences of living with peripheral arterial disease awaiting intervention: A qualitative study. Int J Nurs Stud 2005;42:851–62.
    1. Wann-Hansson C, Rahm Hallberg I, Klevsgård R, Andersson E. The long-term experience of living with peripheral arterial disease and the recovery following revascularisation: A qualitative study. Int J Nurs Stud 2008;45:552–61.
    1. Cunningham MA, Swanson V, Pappas E, OʼCarroll RE, Holdsworth RJ. Illness Beliefs and Walking Behavior After Revascularization for Intermittent Claudication. J Cardiopulm Rehabil Prev 2014;34:195–201.
    1. Lokin JLC, Hengeveld PJ, Conijn AP, Nieuwkerk PT, Koelemay MJW. Disease understanding in patients with intermittent claudication: A qualitative study. J Vasc Nurs 2015;33:112–8.
    1. Carroll C, Booth A, Cooper K. A worked example of “best fit” framework synthesis: A systematic review of views concerning the taking of some potential chemopreventive agents. BMC Med Res Methodol 2011;11:29
    1. Hiatt WR. Quality of life assessment in peripheral arterial disease. Atherosclerosis 1997;131 Suppl:S35–6.
    1. Rejeski WJ, Tian L, Liao Y, McDermott MM. Social cognitive constructs and the promotion of physical activity in patients with peripheral artery disease. J Cardiopulm Rehabil Prev 2008;28:65–72. 01273116-200801000-00013 [pii].
    1. Johnstone CC. Living with peripheral vascular disease: a review of the literature. Prof Nurse 2003;18:446–9.
    1. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American college of cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e726–79.
    1. Criqui " ·b MH, Denenberg J O, Bird CE, Fronek " ·d A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996;1:65–71.
    1. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001;286:1599–606. doi:joc10168 [pii].
    1. O’Donnell ME, Reid JA, Lau LL, Hannon RJ, Lee B. Optimal management of peripheral arterial disease for the non-specialist. Ulster Med J 2011;80:33–41.
    1. Cooke JP, Chen Z. A Compendium on Peripheral Arterial Disease. Circ Res 2015;116:1505–8.
    1. Walker CM, Bunch FT, Cavros NG, Dippel EJ. Multidisciplinary approach to the diagnosis and management of patients with peripheral arterial disease. Clin Interv Aging 2015;10:1147–53.
    1. Willigendael EM, Teijink JAW, Bartelink ML, Boiten J, Moll FL, Büller HR, et al. Peripheral arterial disease: Public and patient awareness in the Netherlands. Eur J Vasc Endovasc Surg 2004;27:622–8.
    1. Carthy ER. Lower Limb Peripheral Arterial Disease (Clinical Guideline 147): A Guideline Summary. Ann Med Surg 2013;2:26–30.
    1. Layden J, Michaels J, Bermingham S, Higgins B. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. BMJ (British Med Journal) 2012;345:e4947–e497.
    1. Lin Y-S, Tung T-H, Wang J, Chen Y-F, Chen T-H, Lin M-S, et al. Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study. Int J Cardiol 2016;203
    1. Dumville JC, Lee AJ, Smith FB, Fowkes FG. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pr 2004;54:826–31.
    1. Ayeed S Bin Hussain MA, AlHamzah M, Al-Omran M. Poor knowledge of peripheral arterial disease among the Saudi population: A cross-sectional study. Vascular 2017;25:86–91.
    1. El Morr C, AlHamzah M, Ng P, Purewal A, Al-Omran M. Knowledge of peripheral arterial disease: Results of an intervention to measure and improve PAD knowledge in Toronto. Vascular 2017:1708538116689355.
    1. Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM, et al. Gaps in public knowledge of peripheral arterial disease: The first national PAD public awareness survey. Circulation 2007;116:2086–94.
    1. Watson K, Watson BD, Pater KS. Peripheral Arterial Disease: A Review of Disease Awareness and Management. Am J Geriatr Pharmacother 2006;4:365–79.
    1. McDermott MM, Mazor KM, Reed G, Pagoto S, Graff R, Merriam P, et al. Attitudes and behavior of peripheral arterial disease patients toward influencing their physiciangs prescription of cholesterol-lowering medication. Vasc Med 2010;15:83–90.
    1. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008;336:491–5.
    1. Abaraogu UO, Dall PM, Seenan CA. The Effect of Structured Patient Education on Physical Activity in Patients with Peripheral Arterial Disease and Intermittent Claudication: A Systematic Review. Eur J Vasc Endovasc Surg 2017.
    1. Cavalcante BR, Farah BQ, Barbosa JPDA, Cucato GG, Chehuen MDR, Santana FDS, et al. Are the barriers for physical activity practice equal for all peripheral artery disease patients? Arch Phys Med Rehabil 2015;96:248–52.
    1. Barbosa J, Farah B, Chehuen M, Cucato G, Farias Júnior J, Wolosker N, et al. Barriers to Physical Activity in Patients with Intermittent Claudication. Int J Behav Med 2015;22:70–6.
    1. Galea MN, Bray SR. Determinants of walking exercise among individuals with intermittent claudication: Does pain play a role? J Cardiopulm Rehabil Prev 2007;27:107–13.
    1. Farah B, Souza-Barbosa J, Cucato G, Chehuen M, Gobbo L, Wolosker N, et al. Predictors of walking capacity in peripheral arterial disease patients. Clinics 2013;68:537–41.
    1. Dörenkamp S, Mesters I, De Bie R, Teijink J, Van Breukelen G. Patient characteristics and comorbidities influence walking distances in symptomatic peripheral arterial disease: A large one-year physiotherapy cohort study. PLoS One 2016;11
    1. Gardner AW, Parker DE, Montgomery PS. Predictors of Improved Walking after a Supervised Walking Exercise Program in Men and Women with Peripheral Artery Disease. Int J Vasc Med 2016;2016
    1. Kruidenier LM, Nicolaï SPA, Ten Bosch JA, de Bie RA, Prins MH, Teijink JAW. Predictors of Walking Distance After Supervised Exercise Therapy in Patients with Intermittent Claudication. Eur J Vasc Endovasc Surg 2009;38:449–55.
    1. Sharath SE, Kougias P, Barshes NR. The influence of pain-related beliefs on physical activity and health attitudes in patients with claudication: A pilot study. Vasc Med (United Kingdom) 2017;22:378–84.
    1. Galea MN, Bray SR, Martin Ginis KA. Barriers and facilitators for walking in individuals with intermittent claudication. J Aging Phys Act 2008;16:69–84.
    1. Abaraogu U, Ezenwankwo E, Dall P, Tew G, Stuart W, Brittenden J, et al. Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program. PLoS One 2018;13:e0201095
    1. Arigo D, Suls JM, Smyth JM. Social comparisons and chronic illness: research synthesis and clinical implications. Health Psychol Rev 2014;8:154–214.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться